Lineage Cell Therapeutics (LCTX) Earnings Date & Reports
A.I. Advisor
published Earnings
LCTX is expected to report earnings to rise 39.00% to -4 cents per share on November 06
Q3'24
Est.
$-0.04
Q2'24
Beat
by $0.02
Q1'24
Est.
$-0.04
Q4'23
Beat
by $0.01
Q3'23
Beat
by $0.01
The last earnings report on August 08 showed earnings per share of -2 cents, beating the estimate of -4 cents. With 395.61K shares outstanding, the current market capitalization sits at 173.73M.